SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001439222-20-000059
Filing Date
2020-07-30
Accepted
2020-07-30 10:25:52
Documents
79
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agio-20200630.htm   iXBRL 10-Q 2172229
2 EX-10.2 a102agiosroyaltypharma.htm EX-10.2 454923
3 EX-31.1 exhibit31-1x06x30x20.htm EX-31.1 11816
4 EX-31.2 exhibit31-2x06x30x20.htm EX-31.2 11907
5 EX-32.1 exhibit32-1x06x30x20.htm EX-32.1 6201
6 EX-32.2 exhibit32-2x06x30x20.htm EX-32.2 6265
  Complete submission text file 0001439222-20-000059.txt   8713262

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agio-20200630.xsd EX-101.SCH 59074
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agio-20200630_cal.xml EX-101.CAL 88005
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agio-20200630_def.xml EX-101.DEF 226911
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agio-20200630_lab.xml EX-101.LAB 531082
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agio-20200630_pre.xml EX-101.PRE 399808
12 EXTRACTED XBRL INSTANCE DOCUMENT agio-20200630_htm.xml XML 1547520
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS, INC. (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36014 | Film No.: 201059641
SIC: 2834 Pharmaceutical Preparations